WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 401

Legislative bill overview

HB 401 is a Kentucky bill relating to medicinal cannabis that was introduced in the House on January 15, 2026. The bill has been referred to the Committee on Committees but no detailed text or specific provisions are publicly available yet. Without access to the full bill language, the precise scope—whether it establishes a medical cannabis program, expands existing provisions, or addresses regulatory matters—cannot be determined.

Why is this important

Medical cannabis legislation affects patient access to treatment options, state regulatory frameworks, healthcare provider guidelines, and potential tax revenue. Kentucky's approach to medicinal cannabis could influence how patients with qualifying conditions access cannabis-based treatments and establish the state's regulatory infrastructure around production, distribution, and quality control.

Potential points of contention

  • Patient access vs. federal conflict: Medicinal cannabis remains federally illegal under Schedule I, creating tension between state authorization and federal law, affecting banking, interstate commerce, and provider liability
  • Qualifying conditions and medical criteria: Disagreement likely over which conditions justify medical cannabis use and whether decisions rest with physicians, state boards, or legislative definition
  • Regulatory and testing standards: Questions about licensing requirements, product testing, potency limits, safety standards, and enforcement mechanisms to prevent misuse or contamination

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.